• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中低收入国家紧急运输系统经济评价中的方法学问题。

Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countries.

机构信息

Institute of Applied Health Research, University of Birmingham, Birmingham, UK

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

出版信息

BMJ Glob Health. 2021 Mar;6(3). doi: 10.1136/bmjgh-2020-004723.

DOI:10.1136/bmjgh-2020-004723
PMID:33737285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7977070/
Abstract

A recent systematic review identified few papers on the economic evaluation of systems for emergency transport of acutely ill or injured patients. In addition, we found no articles dealing with the methodological challenges posed by such studies in low-income or middle-income countries. We therefore carried out an analysis of issues that are of particular salience to this important topic. This is an intellectual study in which we develop models, identify their limitations, suggest potential extensions to the models and discuss priorities for empirical studies to populate models. First, we develop a general model to calculate changes in survival contingent on the reduced time to treatment that an emergency transport system is designed to achieve. Second, we develop a model to estimate transfer times over an area that will be served by a proposed transfer system. Third, we discuss difficulties in obtaining parameters with which to populate the models. Fourth, we discuss costs, both direct and indirect, of an emergency transfer service. Fifth, we discuss the issue that outcomes other than survival should be considered and that the effects of a service are a weighted sum over all the conditions and severities for which the service caters. Lastly, based on the above work, we identify priorities for research. To our knowledge, this is the first study to identify and frame issues in the health economics of acute transfer systems and to develop models to calculate survival rates from basic parameters, such as time delay/survival relationships, that vary by intervention type and context.

摘要

最近的一项系统评价发现,关于急症或重伤患者紧急转运系统的经济评估方面的文献很少。此外,我们没有发现任何针对低收入和中等收入国家此类研究所提出的方法学挑战的文章。因此,我们对这一重要主题的特别突出问题进行了分析。这是一项智力研究,我们在其中建立模型,识别其局限性,提出对模型的潜在扩展,并讨论优先进行实证研究以充实模型的问题。首先,我们开发了一个通用模型,以计算在紧急转运系统设计旨在实现的治疗时间减少的情况下生存情况的变化。其次,我们开发了一个模型来估计在拟议的转运系统服务区域内的转移时间。第三,我们讨论了获取用于填充模型的参数的困难。第四,我们讨论了直接和间接的紧急转运服务成本。第五,我们讨论了应该考虑除生存以外的其他结果的问题,以及服务的效果是服务所针对的所有条件和严重程度的加权总和。最后,基于上述工作,我们确定了研究的优先事项。据我们所知,这是第一项针对急性转运系统的健康经济学中的问题进行识别和阐述,并开发模型来根据时间延迟/生存关系等基本参数计算生存率的研究,这些参数因干预类型和背景而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb1/7977070/c9313b1291ed/bmjgh-2020-004723f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb1/7977070/c9313b1291ed/bmjgh-2020-004723f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb1/7977070/c9313b1291ed/bmjgh-2020-004723f01.jpg

相似文献

1
Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countries.中低收入国家紧急运输系统经济评价中的方法学问题。
BMJ Glob Health. 2021 Mar;6(3). doi: 10.1136/bmjgh-2020-004723.
2
Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.经济评估在低收入和中等收入国家的乳腺癌护理:范围综述。
Oncologist. 2021 Aug;26(8):e1406-e1417. doi: 10.1002/onco.13841. Epub 2021 Jun 5.
3
Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income Countries.在低收入和中等收入国家进行经济评估时收集数据以估计贫困影响时需考虑的方法学问题。
Health Econ. 2016 Feb;25 Suppl 1(Suppl Suppl 1):42-52. doi: 10.1002/hec.3304. Epub 2016 Jan 15.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Financial arrangements for health systems in low-income countries: an overview of systematic reviews.低收入国家卫生系统的财务安排:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD011084. doi: 10.1002/14651858.CD011084.pub2.
6
Economic Burden of Chronic Ill Health and Injuries for Households in Low- and Middle-Income Countries低收入和中等收入国家家庭慢性疾病和伤害的经济负担
7
Economics of physical activity in low-income and middle- income countries: a systematic review.低收入和中等收入国家体力活动经济学:系统评价。
BMJ Open. 2021 Jan 15;11(1):e037784. doi: 10.1136/bmjopen-2020-037784.
8
Delivery arrangements for health systems in low-income countries: an overview of systematic reviews.低收入国家卫生系统的交付安排:系统评价综述
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD011083. doi: 10.1002/14651858.CD011083.pub2.
9
Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.中低收入国家的流感疫苗:系统评价经济评估。
Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31.
10
Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review.经济评估在中低收入国家实施科学成果:范围综述。
Implement Sci. 2022 Nov 16;17(1):76. doi: 10.1186/s13012-022-01248-x.

引用本文的文献

1
Predicting the effects of introducing an emergency transport system in low-income and middle-income countries: a spatial-epidemiological modelling study.预测在低收入和中等收入国家引入紧急运输系统的效果:一项空间流行病学建模研究。
BMJ Public Health. 2024 Feb 20;2(1):e000321. doi: 10.1136/bmjph-2023-000321. eCollection 2024 Jun.
2
Global Insights on Prehospital Stroke Care: A Comprehensive Review of Challenges and Solutions in Low- and Middle-Income Countries.全球院前卒中护理洞察:低收入和中等收入国家挑战与解决方案的全面综述
J Clin Med. 2024 Aug 14;13(16):4780. doi: 10.3390/jcm13164780.

本文引用的文献

1
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme.评估干扰素-β和醋酸格拉替雷在多发性硬化症中的长期疗效:来自英国多发性硬化症风险分担计划的最终 10 年结果。
J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):251-260. doi: 10.1136/jnnp-2018-318360. Epub 2018 Sep 21.
2
Predictive Factors for Death After Snake Envenomation in Myanmar.缅甸蛇伤中毒后死亡的预测因素
Wilderness Environ Med. 2018 Jun;29(2):166-175. doi: 10.1016/j.wem.2018.01.001. Epub 2018 Mar 21.
3
A global map of travel time to cities to assess inequalities in accessibility in 2015.
全球城市出行时间图评估 2015 年可达性的不平等。
Nature. 2018 Jan 18;553(7688):333-336. doi: 10.1038/nature25181. Epub 2018 Jan 10.
4
Evaluating the Health Impact of Large-Scale Public Policy Changes: Classical and Novel Approaches.评估大规模公共政策变革对健康的影响:经典方法与新方法
Annu Rev Public Health. 2017 Mar 20;38:351-370. doi: 10.1146/annurev-publhealth-031816-044208.
5
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.国家层面的成本效益阈值:初步估计及进一步研究的必要性。
Value Health. 2016 Dec;19(8):929-935. doi: 10.1016/j.jval.2016.02.017.
6
EMS Systems in Lower-Middle Income Countries: A Literature Review.低收入和中等收入国家的急救医疗服务系统:文献综述
Prehosp Disaster Med. 2017 Feb;32(1):64-70. doi: 10.1017/S1049023X1600114X. Epub 2016 Dec 12.
7
Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review.全球北方国家成年人就医的出行时间或距离差异是否会对健康结果产生影响?一项系统综述。
BMJ Open. 2016 Nov 24;6(11):e013059. doi: 10.1136/bmjopen-2016-013059.
8
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家310种疾病和损伤的发病率、患病率及伤残调整生命年:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6.
9
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.《健康与医疗领域成本效益分析的实施、方法学实践和报告推荐:第二版》。
JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195.
10
Clinical Guidelines: A NICE Way to Introduce Cost-Effectiveness Considerations?临床指南:引入成本效益考量的好方法?
Value Health. 2016 Jul-Aug;19(5):525-30. doi: 10.1016/j.jval.2016.04.020. Epub 2016 Jun 28.